A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy (Q33335556)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy |
scientific article |
Statements
1 reference
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy (English)
1 reference
S Kakolyris
1 reference
J Souglakos
1 reference
S Agelaki
1 reference
C H Kourousis
1 reference
D Mavroudis
1 reference
E Sarra
1 reference
P Malliotakis
1 reference
V Georgoulias
1 reference
1 December 2000
1 reference
1 reference
30
1 reference
193-198
1 reference
Identifiers
1 reference
1 reference